Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Georgia for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Georgia only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Georgia (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Vasileios Assikis (NPI 1730147596)

Field	Value
Entity Type	Individual
Organization	Vasileios Assikis
Address	775 Poplar Rd Ste 310
City	Newnan
State	GA
ZIP	30265
Taxonomy	Hematology & Oncology Physician
NPI Enumerated	May 2, 2006

Payer Source	Total Paid
Medicare	$3M
Medicaid	$0

Key Findings

This provider is effectively single-payer: lifetime Medicare revenue is $3M while there is no Medicaid billing on file, indicating the practice’s Medicare business dominates its public-payer mix and Medicaid is not a source of reimbursed services for this NPI. Analysts should treat Medicaid-related competitive or utilization comparisons as not applicable for this NPI.

Revenue is highly concentrated in a small set of drug codes: the precomputed top 3 Medicare codes by revenue account for 80.1% of the provider’s total Medicare revenue. The largest single contributor is J9271 (pembrolizumab), which alone represents $1.3M and 45.0% of Medicare revenue, signaling dependence on high-cost oncology immunotherapy infusions.

The code mix and dominant revenue drivers identify the practice as a hematology/oncology infusion and drug administration operation: top codes include J9271 (pembrolizumab), J9299 (nivolumab), and J0897 (denosumab), plus multiple chemotherapy administration CPTs (96413, 96402, 96417). Together these imply routine delivery of systemic cancer therapies, supportive bone-targeted agents, and in-office infusion services.

Competitive standing on key oncology drugs is strong nationally: J9271 ranks #83 of 1841 providers (95th percentile) and J9299 ranks #74 of 505 providers (86th percentile), indicating this provider delivers pembrolizumab and nivolumab at volumes well above most peers. J0897 also ranks highly at the 97th percentile (#308 of 10057), reinforcing that many of the provider’s highest-revenue items are far above typical national volumes.

There are extreme outlier signals on several administration codes and specific products that merit operational attention. The provider is an extreme outlier for J3315 (triptorelin pamoate) at rank #1 of 73 providers and for 96402 at rank #9 of 4765 providers; both are described as "extreme outlier, far above typical national volume" or "100th percentile," which indicates unusually high utilization of these particular drugs or administration services relative to national peers. Additionally, several chemotherapy administration and E/M codes are described as "notably above typical" or high-percentile, supporting the characterization of above-average infusion throughput.

Practice tenure is long: the NPI was enumerated on 2006-05-02 (~20 years ago), suggesting an established provider with sustained Medicare participation over two decades, which can affect referral patterns, patient panel stability, and payer contracting leverage.

While E/M and routine lab codes (for example 99214, 99213, and 85025) appear on the list, they account for a small share of revenue (individual line items at or below ~1.9% and ~0.4% respectively), indicating the business model is centered on high-cost infused drugs and chemotherapy services rather than office visits or ancillary lab revenue. This distribution is consistent with a specialty oncology practice that bills primarily for drug therapy administration.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

57 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J9271	Injection, pembrolizumab, 1 mg	33,400	$40	$1.3M
J9299	Injection, nivolumab, 1 mg	30,880	$20	$710.2K
J0897	Injection, denosumab, 1 mg	19,440	$20	$330.5K
J3315	Injection, triptorelin pamoate, 3.75 mg	530	$280	$145.4K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	790	$90	$74.2K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	630	$90	$56.5K
J1437	Injection, ferric derisomaltose, 10 mg	3,200	$20	$51.2K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	800	$60	$50.1K
Q5107	Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg	2,210	$20	$48.6K
J9217	Leuprolide acetate (for depot suspension), 7.5 mg	280	$130	$35K

Showing 1–10 of 57

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 57 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Georgia Distribution

Vasileios Assikis — 7 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Georgia

Full comparison — all codes billed, vs. state median

57 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J9271	4	40	15,200	$40	$767.3K
J9299	2	10	15,910	$20	$431.3K
J0897	12	290	2,460	$20	$90.2K
Q5107	5	10	3,280	$20	$69.8K
J1437	14	30	2,850	$20	$56.4K
J3315	1	10	140	$290	$56.2K
J1454	13	20	80	$330	$25.9K
96413	2	160	170	$90	$20.3K
J1442	5	10	20,460	$1	$20K
J9217	10	120	110	$130	$20K

Showing 1–10 of 57

Related Providers

Other providers that share a Tax Identification Number (TIN) with Vasileios Assikis, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Emory Medical Care Foundation Inc	GA	Internal Medicine Physician	$0	$41.4M
The Emory Clinic Inc	GA	Ambulatory Surgical Clinic/Center	$1.4M	$26.6M
Somc Medical Care Foundation, Inc.	OH	Family Medicine Physician	$0	$25.3M
Christopher Stelton	FL	Retina Specialist (Ophthalmology) Physician	$4.2M	$0
Joseph Ricotta	FL	Vascular Surgery Physician	$4M	$0
Jorge Fortun	FL	Ophthalmology Physician	$3.7M	$0
Robin Ray	GA	Ophthalmology Physician	$3.5M	$0
Jonathan Bender	GA	Hematology & Oncology Physician	$2.6M	$0
Minesh Patel	GA	Hematology & Oncology Physician	$2.4M	$0
Vipin Ramprasad Lohiya	GA	Hematology & Oncology Physician	$2.3M	$0

Nearby Providers

Other providers in the same ZIP code as Vasileios Assikis, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Wellstreet Of Georgia PC	GA	Urgent Care Clinic/Center	$0	$42.5M
Adonness Bell	GA	Family Nurse Practitioner	$53.9K	$5.6M
My Kidz Dentist, PC	GA	Pediatric Dentistry	$0	$3.9M
Oghenerukevwe Odiete	GA	Interventional Cardiology Physician	$1.2M	$0
Southern Bone & Joint Ambulatory Surgical Center, LLC	GA	Ambulatory Surgical Clinic/Center	$1.2M	$0
Center For Pain And Spine, LLC	GA	Ambulatory Surgical Clinic/Center	$827.2K	$0
Derek Scott	GA	Physical Medicine & Rehabilitation Physician	$593.9K	$0
James Smith	GA	Physician Assistant	$576.9K	$0
Ayesha Faruqi	GA	Internal Medicine Physician	$262.5K	$0
David Harvey	GA	MOHS-Micrographic Surgery Physician	$258.4K	$0

Vasileios Assikis — Billing Profile & Reimbursement Data

Sign up for Vasileios Assikis — Billing Profile & Reimbursement Data policy alerts

Vasileios Assikis — Billing Profile & Reimbursement Data

Sign up for Vasileios Assikis — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References